• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康成年受试者中左氧氟沙星和环丙沙星的稳态血浆浓度及肺内浓度。

Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.

作者信息

Gotfried M H, Danziger L H, Rodvold K A

机构信息

Pulmonary Associates PA, University of Arizona, Phoenix, AZ, USA.

出版信息

Chest. 2001 Apr;119(4):1114-22. doi: 10.1378/chest.119.4.1114.

DOI:10.1378/chest.119.4.1114
PMID:11296178
Abstract

STUDY OBJECTIVE

To determine the steady-state plasma, epithelial lining fluid (ELF), and alveolar macrophage (AM) concentrations of levofloxacin and ciprofloxacin.

DESIGN

Multiple-dose, open-label, randomized pharmacokinetic study.

PARTICIPANTS

Thirty-six healthy, nonsmoking adult subjects were randomized either to oral levofloxacin, 500 or 750 mg once daily for five doses, or ciprofloxacin, 500 mg q12h for nine doses.

INTERVENTIONS

Venipuncture, bronchoscopy, and BAL were performed in each subject at 4 h, 12 h, or 24 h after the last administered dose of antibiotic.

MEASUREMENT AND RESULTS

Mean plasma concentrations of levofloxacin and ciprofloxacin were similar to those previously reported. For once-daily dosing of levofloxacin, 500 mg, the mean (+/- SD) steady-state concentrations at 4 h, 12 h, and 24 h in ELF were 9.9 +/- 2.7 microg/mL, 6.5 +/- 2.5 microg/mL, and 0.7 +/- 0.4 microg/mL, respectively; AM concentrations were 97.9 +/- 80.0 microg/mL, 36.7 +/- 23.4 microg/mL, and 13.8 +/- 16.0 microg/mL, respectively. For levofloxacin, 750 mg, the mean steady-state concentrations in ELF were 22.1 +/- 14.9 microg/mL, 9.2 +/- 5.3 microg/mL, and 1.5 +/- 0.8 microg/mL, respectively; AM concentrations were 105.1 +/- 65.5 microg/mL, 36.2 +/- 26.1 microg/mL, and 15.1 +/- 2.0 microg/mL, respectively. The concentrations of ciprofloxacin at 4 h and 12 h in ELF were 1.9 +/- 0.9 microg/mL and 0.4 +/- 0.1 microg/mL, respectively; AM concentrations were 34.9 +/- 23.2 microg/mL and 6.8 +/- 5.9 microg/mL, respectively. The differences in the ELF concentrations of the two levofloxacin groups vs those of the ciprofloxacin group were significant (p < 0.05) at each sampling time.

CONCLUSIONS

Levofloxacin was more extensively distributed into intrapulmonary compartments than ciprofloxacin and achieved significantly higher steady-state concentrations in plasma and ELF during the 24 h after drug administration.

摘要

研究目的

测定左氧氟沙星和环丙沙星的稳态血浆浓度、上皮衬液(ELF)浓度及肺泡巨噬细胞(AM)浓度。

设计

多剂量、开放标签、随机药代动力学研究。

参与者

36名健康、不吸烟的成年受试者被随机分为两组,一组口服左氧氟沙星,500或750mg每日一次,共五剂;另一组口服环丙沙星,500mg每12小时一次,共九剂。

干预措施

在每位受试者最后一剂抗生素给药后4小时、12小时或24小时进行静脉穿刺、支气管镜检查和支气管肺泡灌洗(BAL)。

测量与结果

左氧氟沙星和环丙沙星的平均血浆浓度与先前报道的相似。对于每日一次服用500mg左氧氟沙星,ELF在4小时、12小时和24小时的平均(±标准差)稳态浓度分别为9.9±2.7μg/mL、6.5±2.5μg/mL和0.7±0.4μg/mL;AM浓度分别为97.9±80.0μg/mL、36.7±23.4μg/mL和13.8±16.0μg/mL。对于750mg左氧氟沙星,ELF的平均稳态浓度分别为22.1±14.9μg/mL、9.2±5.3μg/mL和1.5±0.8μg/mL;AM浓度分别为105.1±65.5μg/mL、36.2±26.1μg/mL和15.1±2.0μg/mL。环丙沙星在ELF中4小时和12小时的浓度分别为1.9±0.9μg/mL和0.4±0.1μg/mL;AM浓度分别为34.9±23.2μg/mL和6.8±5.9μg/mL。在每个采样时间,两个左氧氟沙星组与环丙沙星组的ELF浓度差异均有统计学意义(p<0.05)。

结论

与环丙沙星相比,左氧氟沙星在肺内各腔室中的分布更广泛,在给药后24小时内血浆和ELF中的稳态浓度显著更高。

相似文献

1
Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.健康成年受试者中左氧氟沙星和环丙沙星的稳态血浆浓度及肺内浓度。
Chest. 2001 Apr;119(4):1114-22. doi: 10.1378/chest.119.4.1114.
2
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.健康成年人静脉注射左氧氟沙星和阿奇霉素后的稳态血浆及支气管肺浓度。
Antimicrob Agents Chemother. 2003 Aug;47(8):2450-7. doi: 10.1128/AAC.47.8.2450-2457.2003.
3
Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.健康志愿者中高剂量左氧氟沙星的肺内药代动力学和药效学
Int J Antimicrob Agents. 2006 Aug;28(2):114-21. doi: 10.1016/j.ijantimicag.2006.03.022. Epub 2006 Jul 11.
4
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.老年人中莫西沙星、左氧氟沙星和阿奇霉素的肺内稳态浓度。
Chest. 2004 Mar;125(3):965-73. doi: 10.1378/chest.125.3.965.
5
Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.高剂量左氧氟沙星在慢性支气管炎或慢性阻塞性肺疾病患者中的肺内药效学
Int J Antimicrob Agents. 2007 Nov;30(5):422-7. doi: 10.1016/j.ijantimicag.2007.05.023. Epub 2007 Aug 22.
6
Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.左氧氟沙星 750mg 每日一次治疗慢性支气管炎急性加重症成人患者的支气管肺部药代动力学和药效学特征。
Pulm Pharmacol Ther. 2012 Feb;25(1):94-8. doi: 10.1016/j.pupt.2011.12.007. Epub 2011 Dec 22.
7
Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.健康志愿者中多次口服每日一次750毫克和1克剂量左氧氟沙星的安全性和药代动力学的双盲评估。
Antimicrob Agents Chemother. 1998 Apr;42(4):885-8. doi: 10.1128/AAC.42.4.885.
8
Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.口服左氧氟沙星在接受齐多夫定治疗的人类免疫缺陷病毒感染个体中的药代动力学和安全性。
Antimicrob Agents Chemother. 1997 Aug;41(8):1765-9. doi: 10.1128/AAC.41.8.1765.
9
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.单次口服剂量的环丙沙星缓释片(1000毫克)与左氧氟沙星(500毫克)在健康男女志愿者血浆和尿液中的药代动力学研究。
Int J Antimicrob Agents. 2006 Jan;27(1):7-14. doi: 10.1016/j.ijantimicag.2005.09.014. Epub 2005 Dec 15.
10
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.塞曲霉素的稳态血浆及肺内药代动力学与药效学
Antimicrob Agents Chemother. 2004 Sep;48(9):3508-15. doi: 10.1128/AAC.48.9.3508-3515.2004.

引用本文的文献

1
Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin.造血干细胞移植受者预防性使用氟喹诺酮类药物:环丙沙星与左氧氟沙星的荟萃分析比较
Medicine (Baltimore). 2025 May 9;104(19):e42317. doi: 10.1097/MD.0000000000042317.
2
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.应用药剂计量学方法制定推荐抗菌药物的改良鲍曼不动杆菌药敏试验解释标准。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0145222. doi: 10.1128/aac.01452-22. Epub 2023 Mar 22.
3
Distribution of enrofloxacin within the bronchoalveolar region of healthy pigs.
恩诺沙星在健康猪的支气管肺泡区域内的分布。
J Vet Med Sci. 2023 Mar 1;85(3):296-300. doi: 10.1292/jvms.22-0416. Epub 2023 Jan 17.
4
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations.基于生理学的抗菌药物靶部位浓度肺部药代动力学预测模型框架。
Clin Pharmacokinet. 2022 Dec;61(12):1735-1748. doi: 10.1007/s40262-022-01186-3. Epub 2022 Nov 19.
5
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part II.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第二部分
Antibiotics (Basel). 2022 Sep 3;11(9):1193. doi: 10.3390/antibiotics11091193.
6
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.健康成年受试者口服替比培南匹伏酯氢溴酸盐后的血浆和肺内替比培南浓度。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0059022. doi: 10.1128/aac.00590-22. Epub 2022 Jun 28.
7
Pharmacokinetics in plasma and alveolar regions of a healthy calf intramuscularly administered a single dose of orbifloxacin.健康犊牛肌肉注射单剂量氧氟沙星后,其血浆和肺泡区域的药代动力学。
J Vet Med Sci. 2022 Mar 15;84(3):400-405. doi: 10.1292/jvms.21-0517. Epub 2022 Jan 28.
8
Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.微剂量给药作为增强新型抗生素临床开发的潜在工具:以环丙沙星为例的组织和血浆 PK 可行性研究。
Clin Pharmacokinet. 2022 May;61(5):697-707. doi: 10.1007/s40262-021-01091-1. Epub 2022 Jan 7.
9
Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.新型和临床应用的结核药物的细胞内蓄积增强了细胞内协同作用。
Microbiol Spectr. 2021 Oct 31;9(2):e0043421. doi: 10.1128/Spectrum.00434-21. Epub 2021 Sep 29.
10
MRGPRX2 and Adverse Drug Reactions.MRGPRX2 与药物不良反应。
Front Immunol. 2021 Aug 6;12:676354. doi: 10.3389/fimmu.2021.676354. eCollection 2021.